Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Xiamen Amoytop Biotech Co., Ltd.

Clinical trials sponsored by Xiamen Amoytop Biotech Co., Ltd., explained in plain language.

Trials to join now! 3 Not yet recruiting 5 Completed 2
Sort by
  • Could a simple injection prevent preeclampsia? early trial begins

    Disease control Completed

    This early-stage trial tested the safety and tolerability of telpegfilgrastim injections in 18 non-pregnant women, including some with a history of preeclampsia. Researchers monitored side effects, drug levels in the blood, and immune markers. The goal is to see if the drug is sa…

    Phase: PHASE1 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control

    Last updated Jun 27, 2026 12:07 UTC

  • New drug for fatty liver disease first tested in healthy volunteers

    Knowledge-focused Completed

    This early-stage study tested the safety of a new drug called ACT500 in 72 healthy Chinese adults. Participants received either the drug or a placebo, and researchers monitored side effects and how the drug moved through the body. The goal was not to treat disease but to gather e…

    Phase: PHASE1 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Knowledge-focused

    Last updated Jun 27, 2026 09:06 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space